<DOC>
	<DOCNO>NCT02448758</DOCNO>
	<brief_summary>The investigator propose create database regional level , principle include patient mutation detect single platform ( Lille ) . The creation regional cohort , small national cohort Biomarkers France , perform comprehensive collection clinical data , molecular monitoring data patient include . To increase completeness collection information , base voluntary prescribing clinician largely carried CRA dedicate activity .</brief_summary>
	<brief_title>Cohort Non-small Cell Lung Cancer With Mutation Nord Pas de Calais ( CB ( NPC ) ² )</brief_title>
	<detailed_description>This prospective retrospective study population patient mutate non-small cell lung cancer Nord Pas de Calais . Retrospective cohort involve patient main molecular abnormality , identifiable molecular biology platform CRRC , except EGFR KRAS treat September 2011 February 2013 .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Aged ≥ 18 year old Patient nonsmall cell lung cancer Detected Nord Pas de Calais Monitored Nord Pas de Calais Patient must sign nonopposition form use medical data No identified mutation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>mutation</keyword>
</DOC>